XML 19 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of allocation of share-based compensation costs by plan
A summary of the expense related to stock-based compensation by award type is as follows for the periods presented:
 
Fiscal Year Ended September 30,
(In thousands)
2019
 
2018
 
2017
Stock options expense
$
178

 
$
225

 
$
274

Restricted stock awards expense
10,348

 
10,033

 
7,885

Stock-based compensation expense
$
10,526

 
$
10,258

 
$
8,159

Schedule of assumptions for stock option activity
We used the following valuation assumptions for stock options granted for the periods presented:
 
Fiscal Year Ended September 30,
 
2019
 
2018
 
2017
Expected life of options
5.0 years

 
5.0 years

 
5.4 years

Expected volatility
46.69
%
 
44.71
%
 
50.10
%
Expected dividends

 

 

Weighted-average risk-free interest rate
2.70
%
 
2.10
%
 
1.85
%
Weighted-average fair value
$
4.50

 
$
8.30

 
$
5.83

 
Fiscal Year Ended September 30,
 
2019
 
2018
 
2017
Expected volatility
21.0% - 57.1%

 
21.1% - 61.2%

 
32.6% - 66.0%

Risk-free interest rate
2.92
%
 
1.81
%
 
1.30
%
Dividend yield

 

 

Grant-date stock price
$
9.82

 
$
20.50

 
$
12.51

Schedule of stock options and SSARs outstanding
Activity related to stock options for the periods presented is as follows:
 
2019
 
2018
 
2017
 
Shares
 
Weighted-
Average
Exercise
Price
 
Shares
 
Weighted-
Average
Exercise
Price
 
Shares
 
Weighted-
Average
Exercise
Price
Outstanding at beginning of period
533,052

 
$
14.26

 
593,753

 
$
14.76

 
672,669

 
$
16.49

Granted
30,782

 
10.23

 
25,230

 
19.99

 
29,410

 
12.50

Exercised
(31,450
)
 
10.00

 
(8,411
)
 
7.52

 
(2,313
)
 
10.80

Expired

 

 
(61,967
)
 
23.19

 
(84,976
)
 
28.45

Cancelled

 

 

 

 
(480
)
 
23.65

Forfeited
(8,630
)
 
10.45

 
(15,553
)
 
10.46

 
(20,557
)
 
11.97

Outstanding at end of period
523,754

 
$
14.34

 
533,052

 
$
14.26

 
593,753

 
$
14.76

Exercisable at end of period
470,501

 
$
14.42

 
479,538

 
$
14.03

 
476,606

 
$
15.91

Vested or expected to vest in the future
521,362

 
$
14.36

 
533,052

 
$
14.26

 
585,186

 
$
14.83

Schedule of stock options and SSARS outstanding and exercisable
The following table summarizes information about stock options outstanding and exercisable as of September 30, 2019:
 
Stock Options Outstanding
 
Stock Options Exercisable
Range of Exercise Price
Number Outstanding
 
Weighted-Average Contractual Remaining Life (Years)
 
Weighted-Average Exercise Price
 
Number Exercisable
 
Weighted-Average Contractual Remaining Life (Years)
 
Weighted-Average Exercise Price
$1 - $10
138,472

 
2.5
 
$
9.79

 
116,980

 
1.6
 
$
9.77

$11 - $15
212,240

 
2.3
 
13.28

 
196,266

 
2.0
 
13.38

$16 - $20
173,042

 
2.7
 
19.30

 
157,255

 
2.3
 
19.19

$1 - $20
523,754

 
2.5
 
$
14.34

 
470,501

 
2.0
 
$
14.42

Schedule of stock options exercised and vested
Information pertaining to the intrinsic value of options exercised and the fair market value of options that vested is below:
 
Fiscal Year Ended September 30,
(In thousands)
2019
 
2018
 
2017
Intrinsic value of options exercised
$
90

 
$
76

 
$
13

Fair market value of options vested
178

 
296

 
482

Schedule of nonvested stock awards and performance shares
Activity relating to all restricted stock awards for the periods presented is as follows:
 
Year Ended September 30, 2019
 
Performance-Based
 
Time-Based
 
Total
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
Beginning of period
644,785

 
$
16.47

 
431,783

 
$
16.60

 
1,076,568

 
$
16.53

Granted (a)
467,819

 
9.95

 
448,657

 
9.82

 
916,476

 
9.89

Vested (a)
(321,833
)
 
15.36

 
(212,558
)
 
16.41

 
(534,391
)
 
15.78

Forfeited
(11,957
)
 
13.44

 
(56,275
)
 
12.20

 
(68,232
)
 
12.42

End of period
778,814

 
$
13.60

 
611,607

 
$
12.11

 
1,390,421

 
$
16.53


(a) Grant and vesting activity during the twelve months ended September 30, 2019 include 86,050 shares that were issued above target based on performance level achieved under performance-based restricted stock vesting in the current period.
 
Year Ended September 30, 2018
 
Performance-Based
 
Time-Based
 
Total
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
Beginning of period
668,766

 
$
15.72

 
872,181

 
$
16.47

 
1,540,947

 
$
16.15

Granted
165,085

 
22.40

 
277,165

 
18.98

 
442,250

 
20.26

Vested

 

 
(690,922
)
 
17.38

 
(690,922
)
 
17.38

Forfeited
(189,066
)
 
18.98

 
(26,641
)
 
17.02

 
(215,707
)
 
18.74

End of period
644,785

 
$
16.47

 
431,783

 
$
16.60

 
1,076,568

 
$
16.53

 
Year Ended September 30, 2017
 
Performance-Based
 
Time-Based
 
Total
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
 
Shares
 
Weighted-
Average
Grant
Date Fair
Value
Beginning of period
448,693

 
$
16.71

 
807,124

 
$
17.52

 
1,255,817

 
$
17.23

Granted
263,696

 
13.60

 
271,855

 
12.50

 
535,551

 
13.04

Vested

 

 
(189,029
)
 
15.52

 
(189,029
)
 
15.52

Forfeited
(43,623
)
 
13.11

 
(17,769
)
 
14.08

 
(61,392
)
 
13.39

End of period
668,766

 
$
15.72

 
872,181

 
$
16.47

 
1,540,947

 
$
16.15